Antimicrobial prophylaxis

Archives of Disease in Childhood

Volumn 80, Issue 4, 1999, Pages 388-392

  Smith, Jason ^a   Finn, Adam ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEPHALOSPORIN; COTRIMOXAZOLE; ERYTHROMYCIN; POVIDONE IODINE; SILVER NITRATE; TETRACYCLINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL ENDOCARDITIS; BITE; CONJUNCTIVITIS; DRUG INDICATION; HUMAN; MENINGITIS; NEWBORN OPHTHALMIA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RASH; RESPIRATORY TRACT INFECTION; REVIEW; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URINARY TRACT INFECTION;

EID: 0032957210     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.80.4.388     Document Type: Review

References (68)

1. Protective measures against malaria. In: International travel and health. Geneva: World Health Organization; 1997. (http://jupiter.who.ch/yellow/protect.htm)
2. Oakley CM. Controversies in the prophylaxis of infective endocarditis: a cardiological view. J Antimicrob Chemother 1987;20(suppl A):99-104.
3. Durack DT, Kaplan EL, Bisno AL. Apparent failures of endocarditis prophylaxis: analysis of 52 cases submitted to a national registry. JAMA 1983;250:2318-22.
4. Longman LP, Martin MV. The prevention of infective endocarditis-paedodontic considerations. British Society for Antimicrobial Chemotherapy. International Journal of Paediatric Dentistry 1993;3:63-70
5. Silver JG, Martin AW, McBride BC. Experimental transient bacteraemias in human subjects with varying degrees of plaque accumulation and gingival inflammation. J Clin Periodontol 1977;4:92-9.
6. Delaye J, Etienne J, Feruglio GA, et al. Prophylaxis of infective endocarditis for dental procedures: report of a working party of the European Society of Cardiology. Eur Heart J 1985;6:826-8.
7. Normand J, Bozio A, Etienne J, Sassolas F, Le Bris H. Changing patterns and prognosis of infective endocarditis in childhood. Eur Heart J 1995;16(suppl B):28-31.
8. Anon. Chemoprophylaxis for infective endocarditis: faith, hope, and charity challenged. Lancet 1992;339:525-6.
9. Van der Meer JT, Van Wijk W, Thompson J, Vandenbroucke JP, Valkenburg HA, Michel MF. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992;339:135-9.
10. Simmons NA. Recommendations for endocarditis prophylaxis: endocarditis working party for antimicrobial chemotherapy. J Antimicrob Chemother 1993;31:437-8.
11. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801.
12. Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg 1993;128:79-88.
13. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 1995;37:79-82.
14. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis 1994;18:422-7.
15. Lally KP, Kanegaye J, Matsumura M, Rosenthal P, Sinatra F, Atkinson JB. Perioperative factors affecting the outcome following repair of biliary atresia. Pediatrics 1989;83:723-6.
16. Soderquist Elinder C, Hirsch K, Bergdahl S, Rutqvist J, Frenckner B. Prophylactic antibiotics in uncomplicated appendicitis during childhood: a prospective randomised study. Eur J Pediatr Surg 1995;5:282-5.
17. Thomson SR, Carle G, Reid TM, Davidson AJ, Miller SS. Antibiotic prophylaxis in non-perforated appendicitis of childhood: tetracycline lavage compared with peroperative intravenous cefuroxime and metronidazole. J Hosp Infect 1987;9:158-61.
18. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995;169:480-3.
19. Andrejak M, Schmit JL, Tondriaux A. The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s. Drug Saf 1991;6:339-49.
20. Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med 1995;332:562-6.
21. Ratelle S, Keno D, Hardwood M, Etkind PH. Neonatal chlamydial infections in Massachusetts, 1992-1993. Am J Prev Med 1997;13:221-4.
22. Rathore MH. Do prophylactic antibiotics prevent meningitis after basilar skull fracture? Pediatr Infect Dis J 1991;10:87-8.
23. Ignelzi RJ, VanderArk GD. Analysis of the treatment of basilar skull fractures with and without antibiotics. J Neurosurg 1975;43:721-6
24. Cummings P. Antibiotics to prevent infection in patients with dog bite wounds: a meta-analysis of randomized trials. Ann Emerg Med 1994;23:535-40.
25. Warshafsky S, Nowakowski J, Nadelman RB, Kamer RS, Peterson SJ, Wormser GP. Efficacy of antibiotic prophylaxis for prevention of Lyme disease. J Gen Intern. Med 1996;11:329-33.
26. Benson M, Jodal U, Agace W, et al. Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asymptomatic bacteriuria. J Infect Dis 1996;174:1080-4.
27. Bergstrom T, Larson H, Lincoln K, Winberg J. Studies of urinary tract infections in infancy and childhood. XII. Eighty consecutive patients with neonatal infection. J Pediatr 1972;80:858-66.
28. Gruneberg RN, Smellie JM, Leakey A, Atkin WS. Long-term low-dose cotrimoxazole in prophylaxis of childhood urinary tract infection: bacteriological aspects. BMJ 1976;ii:206-8.
29. Medical versus surgical treatment of primary vesicoureteral reflux: a prospective international reflux study in children. J Urol 1981;125:277-83.
30. Edwards D, Normand IC, Prescod N, Smellie JM. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. BMJ 1977;ii:285-8.
31. Arant BS. Medical management of mild and moderate vesicoureteral reflux: followup studies of infants and young children: a preliminary report of the southwest pediatric nephrology study group. J Urol 1992;148:1683-7.
32. Pilling D, Postlethwaite R. Imaging in urinary tract infection. London: British Paediatric Association Committee on Paediatric Practice Guidelines, 1996.
33. Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen MTE. International system of radiographic grading of vesicoureteric reflux. International reflux study in children. Pediatr Radiol 1985;15:105-9.
34. Jodal U, Koskimies O, Hanson E, et al. Infection pattern in children with vesicoureteral reflux randomly allocated to operation or long-term antibacterial prophylaxis. International reflux study in children. J Urol 1992;148:1650-2.
35. Smith EM, Elder JS. Double antimicrobial prophylaxis in girls with breakthrough urinary tract infections. Urology 1994;43:708-12.
36. Weiss R, Duckett J, Spitzer A. Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). International reflux study in children. J Urol 1992;148:1667-73.
37. Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years' observation. Birmingham reflux study group. BMJ Clin Res 1987;295:237-41.
38. Scott JE, Swallow V, Coulthard MG, Lambert HJ, Lee RE. Screening of newborn babies for familial ureteric reflux. Lancet 1997;350:396-400.
39. Rosse WF. The spleen as a filter. N Engl J Med 1987;317:704-6.
40. Cullingford GL, Watkins DN, Watts AD, Mallon DF. Severe late postsplenectomy infection. Br J Surg 1991;78:716-21.
41. Traub A, Giebink GS, Smith C, et al. Splenic reticuloendothelial function after splenectomy, spleen repair, and spleen autotransplantation. N Engl J Med 1987;317:1559-64.
42. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991;78:1031-8.
43. Rosner F, Zarrabi MH, Benach JL, Habicht GS. Babesiosis in splenectomized adults: review of 22 reported cases. Am J Med 1984;76:696-701.
44. McCarthy M, Zumla A. DF-2 infection. BMJ 1988;297:1355-6.
45. Edwards LD, Digioia R. Infections in splenectomized patients: a study of 131 patients. Scand J Infect Dis 1976;8:255-61.
46. Oster CN, Koontz LC, Wyler DJ. Malaria in asplenic mice: effects of splenectomy, congenital asplenia, and splenic reconstitution on the course of infection. Am J Trop Med Hyg 1980;29:1138-42.
47. Scopes JW. Continued need for pneumococcal prophylaxis after splenectomy. Arch Dis Child 1991;66:750.
48. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. BMJ 1996;312:430-4
49. Holdsworth RJ, Irving AD, Cuschieri A. Postsplenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg 1991;78:1031-8.
50. Chief Medical Officer. Asplenic patients and immunisation. CM0's update 1994;1:3.
51. Fischl MA, Dickinson GM, La Voie L. Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA 1988;259:1185-9.
52. 1995 Revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR Recommendations and Reports 1995;44:1-11.
53. Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. Consensus panel for the diagnosis and management of primary antibody deficiencies. BMJ 1994;308:581-5.
54. Williams RL, Chalmers TC, Stange KC, Chalmers FT, Bowlin SJ. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion: a meta-analytic attempt to resolve the brouhaha. JAMA 1993;270:1344-51.
55. Liston TE, Foshee WS, Pierson WD. Sulfisoxazole chemoprophylaxis for frequent otitis media. Pediatrics 1983;71:524-30.
56. Varsano I, Volovitz B, Mimouni F. Sulfisoxazole prophylaxis of middle ear effusion and recurrent acute otitis media. Am J Dis Child 1985;139:632-5.
57. Principi N, Marchisio P, Massironi E, Grasso RM, Filiberti G. Prophylaxis of recurrent acute otitis media and middle-ear effusion: comparison of amoxicillin with sulfamethoxazole and trimethoprim. Am J Dis Child 1989;143:1414-8
58. Sih T, Moura R, Caldas S, Schwartz B. Prophylaxis for recurrent acute otitis media: a Brazilian study. Int J Pediatr Otorhinolaryngol 1993;25:19-24.
59. Prellner K, Fogle Hansson M, Jorgensen F, Kalm O, Kamme C. Prevention of recurrent acute otitis media in otitis-prone children by intermittent prophylaxis with penicillin. Acta Otolaryngol Stockh 1994;114:182-7.
60. Nydahl Persson K, Petterson A, Fasth A. A prospective, double-blind, placebo-controlled trial of iv immunoglobulin and trimethoprim-sulfamethoxazole in children with recurrent respiratory tract infections. Acta Paediatr 1995;84:1007-9.
61. Howe RA, Spencer RC. Cotrimoxazole. Rationale for re-examining its indications for use. Drug Saf 1996;14:213-18
62. Gutman LT. The use of trimethoprim-sulfamethoxazole in children: a review of adverse reactions and indications. Pediatr Infect Dis 1984;3:349-57
63. Anderson JA. Antibiotic drug allergy in children. Curr Opin Pediatr 1994;6:656-60.
64. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: a population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990;126:43-7.
65. Jick H, Derby LE. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity. Pharmacotherapy 1995;15:428-32.
66. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
67. Myers MW, Jick H. Hospitalization for serious blood and skin disorders following cotrimoxazole. Br J Clin Pharmacol 1997;43:649-51.
68. Schopf E. Skin reactions to co-trimoxazole. Infection 1987;15(suppl 5):S254-8.